Efficacy of thrice-weekly long-acting insulin degludec provided by nurses in handicapped patients with type 2 diabetes on maintenace hemodialysis teratment

Efficacy of thrice-weekly long-acting insulin degludec provided by nurses in handicapped patients with type 2 diabetes on maintenace hemodialysis teratment - thrice-weekly long-acting insulin degludec provided by nurses in handicapped patients

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000038149

Enrollment

Registered

2019-10-20

Start date

2019-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type2 diabetes on hemodialysis treatment

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. type 2 diabetes 2. hemodialysis patients 3. poor control of blood glucose even after dietary therapy and OHA 4. self-injection is impossible

Exclusion criteria

Exclusion criteria: 1. type 1 diabetes 2. self-injection is impossible

Design outcomes

Primary

Measure	Time frame
control of blood glucose status at 3 months after fixting insulin dosage	—

Countries

Japan

Contacts

Public ContactToshiyuki Nakao

Organization for Kidney and Metabolic Disease Ttreatment Bouosei nishishinjuku shinryojo

t-nakao@tokyo-med.ac.jp03-5340-5680

Outcome results